(Thomson Reuters ONE) - OKMETIC OYJINTERIM REPORT31 JULY 2009, AT 10.00 AMOkmetic is a technology company that supplies customised siliconwafers for the sensor and semiconductor industries and sells itstechnological expertise to the solar energy industry. During theperiod under review, the company's net sales amounted to 28.4 millioneuro (34.0 million euro). Profit for the period was 1.1 million euro(4.1 million euro). Earnings per share were 0.06 euro (0.24 euro).REVIEW IN BRIEF- The net sales in the first half of the year amounted to 28.4million euro (34.0 million euro) and in the second quarter to 13.5million euro (17.0 million euro).- The operating profit before depreciation (EBITDA) in the first halfof the year was 4.7 million euro (8.8 million euro) and in the secondquarter 2.4 million euro (4.5 million euro).- The operating profit in the first half of the year was 1.2 millioneuro (5.3 million euro) and in the second quarter 0.7 million euro(2.7 million euro).- Profit for the period was 1.1 million euro (4.1 million euro). Inthe second quarter the profit for the period was 0.0 million euro(2.4 million euro).- Earnings per share were 0.06 euro (0.24 euro).- The net cash flow from operations in the first half of the yearamounted to 4.3 million euro (5.8 million euro) and in the secondquarter to 4.8 million euro (3.5 million euro).- At the end of the period, the company's cash and cash equivalentsexceeded the interest-bearing liabilities by 2.9 million euro (6.2million euro lower).- The company has no subordinated loans anymore.- Sales of sensor wafers are almost on a par with 2008 levels, whilesales of semiconductor wafers have fallen substantially. Significantthree-year technology sales project has been carried out almostentirely. The project has been extremely successful.- Majority of the company's personnel in Finland were temporarilylaid off from one to six weeks in February-June 2009.- The market situation being as it is, there is great uncertaintyconcerning the estimate on net sales and performance in 2009. Netsales for the year 2009 are expected to amount to around 54 millioneuro. Operating profit is estimated to be slightly positive. Cashflow from operating activities is expected to be clearly positive.The group continues to adjust its expenses to the prevailing marketsituation.KEY FIGURES1,000 euro 1.1.- 1.1.- 1.1.- 1.1.- 1.1.- 30.6.09 30.6.08 31.12.08 31.12.07 31.12.06Net sales 28,379 34,025 67,867 64,652 63,694Operating profit beforedepreciation (EBITDA) 4,668 8,795 15,517 15,216 18,363Operating profit 1,215 5,279 8,476 7,121 9,877 % of net sales 4.3 15.5 12.5 11.0 15.5Profit for the period 1,066 4,072 5,825 5,305 6,886Earnings per share, euro 0.06 0.24 0.34 0.31 0.41Net cash flow fromoperating activities 4,265 5,776 13,177 8,305 17,945Net interest-bearingliabilities -2,898 6,220 -586 8,952 12,547Average number ofpersonnel during theperiod 340 361 364 362 360MARKETSCustomer industriesThe worldwide economic problems in the first half of 2009 hadrepercussions on the demand for electronics in all market areas andtherefore also on Okmetic's customer industries. The sensor industry,where typical annual growth had previously been around 10 percent,now experienced a rare drop in demand as a result of the economicdownturn. At the beginning of the year sales of sensor wafersremained at the same level as a year ago. The market situation in thesemiconductor industry was weak. In the first six months of the year,global invoicing in the sector remained substantially below theprevious year's levels.Silicon wafer industryThe difficult market situation in the customer industries alsoaffected the demand for silicon wafers. Demand fell significantly inthe first quarter due to clients decreasing their stock levels. Inthe second quarter, some of the demand consisted of replenishingthese stocks. Total silicon wafers deliveries decreased significantlycompared to the corresponding period a year ago.OkmeticOkmetic's sales of sensor wafers remained almost at the same level asa year ago, despite the difficult market situation. Sales ofsemiconductor wafers decreased significantly in the first quarter ofthe year as a result of the global market situation. In the secondquarter of the year sales of semiconductor wafers increasedessentially compared to the first quarter. Okmetic continued toincrease its market share in the main product areas.Significant three-year technology sales project has been carried outalmost entirely. The project has been extremely successful.PROJECTIONS FOR THE NEAR FUTURECustomer industriesThe market situation in the sensor industry is expected to remainstable in the second half of the year. Total annual sensor sales areexpected to approach 2008 levels. Total sales of semiconductors areexpected to decrease about 20 percent from 2008 levels. Demand forsemiconductors suffered even more substantially in the first half ofthe year, but at least the third quarter sales are expected to exceedthe level at the beginning of the year.Silicon wafer industryThe general consensus in the industry is that sensor andsemiconductor manufacturers have already started to replenish theirwafer stocks in preparation for partial normalisation of demand.However, total silicon wafer deliveries globally are projected toremain well below 2008 in 2009. The gradual market recovery isexpected to reflect to wafer demand in the rest of the year.OkmeticOkmetic specialises in the manufacture of demanding sensor wafers andis the global market leader and a pioneer in technologicaldevelopment in this respect. This creates a sound basis for thecompany and substantial growth potential when the wafer industry isreturning to a growth track. Forecasts suggest this upturn shouldhappen in 2010. In the second half of 2009 Okmetic's sensor waferdeliveries will be aligned to general market trends and remain at thelevel of the first half of the year. Okmetic's semiconductor waferdeliveries are projected to grow substantially in the second half ofthe year compared with the first. Due to the nearly completed majortechnology project and the low recycling price of silicon, technologysales in the second half of the year are forecasted to remain wellbelow first half sales levels.The market situation being as it is, there is great uncertaintyconcerning the estimate on net sales and performance in 2009. Netsales for the year 2009 are expected to amount to around 54 millioneuro. Operating profit is estimated to be slightly positive. Cashflow from operating activities is expected to be clearly positive.The group continues to adjust its expenses to the prevailing marketsituation.SALESOkmetic's net sales in the first half of the year decreased by 16.6percent from the previous year (increased by 3.3 %), amounting to28.4 million euro (34.0 million euro). In the second quarter the netsales amounted to 13.5 million euro (17.0 million euro). Decreasingnet sales at the end of 2008 followed on from the drastic downturn inthe semiconductor industry's market situation in particular.Semiconductor wafers' market situation is estimated to improve in thesecond half of the year. The company's share of its customers` wafersourcing continued to increase.Net sales per customer area 1.1.- 1.1.- 1.1.- 30.6.09 30.6.08 31.12.08Sensor wafers 38% 35% 37%Semiconductor wafers 22% 39% 38%Technology 40% 26% 25%Okmetic's performance in the sensor market developed according toobjectives, although also the sensor sales remained slightly behindthe previous year. The use of sensors is expected to continue itsincrease. Sensor applications are rapidly becoming more popular incameras and other consumer electronics products, for example, inaddition to the automotive industry and other traditionalapplications.The falling share of semiconductor sales in our total sales is theresult of the weak market situation, which is expected to improve inthe second half of the year. The most typical uses of semiconductorwafers include consumer electronics, information technology,telecommunications and the automotive industry.Technology sales comprise not just manufacturing technology but alsocrystal sales and occasional polysilicon recycling. The significantproject in production technology started three years ago and it hasbeen carried out almost entirely. The project has been extremelysuccessful. The company is striving to close new technology deals bythe end of the year. The fluctuations in sales volume percentages percustomer area and market area are due to the nature of technologysales and irregular income recognition schedule.Net sales per market area 1.1.- 1.1.- 1.1.- 30.6.09 30.6.08 31.12.08North America 35% 38% 39%Europe 35% 39% 33%Asia 30% 23% 28%The exchange rates of the US dollar and Japanese yen against the eurohave an effect on the way net sales are distributed between differentmarket areas.PROFITABILITYOkmetic group's profit for the period was 1.1 million euro (4.1million euro) in January-June 2009. In the second quarter the profitfor the period was 0.0 million euro (2.4 million euro). Earnings pershare were 0.06 euro (0.24 euro). The company's profits were burdenedby the low operating rate resulting from the market situation insemiconductor wafers. Profits are also suffering as a result of thesubstantially lower recycling price received for silicon in thecurrent market situation. All the costs have been adjusted to theprevailing market situation in the group.FINANCING AND INVESTMENTSThe group's financial situation is good. The group's cash and cashequivalents exceeded the interest-bearing liabilities by 2.9 millioneuro (6.2 million euro lower). The net cash flow from operatingactivities in the first half of the year amounted to 4.3 million euro(5.8 million euro) and in the second quarter to 4.8 million euro (3.5million euro). In June the company paid, in line with itsamortisation programme, 1.0 million euro in capital loan instalmentsand associated interest. The company has no subordinated loansanymore.A total of 1.4 million euro was invested in refurbishing productionequipment. The company received 0.6 million euro from the sale ofused machinery.In April, the company paid a dividend of 0.8 million euro of theprofit accrued in 2008.At the end of the period, cash and cash equivalents amounted to 17.2million euro (13.1 million euro). Return on equity amounted to 4.2percent (17.6 %). The group's equity ratio was 67.7 percent (60.1 %).Shareholders' equity per share amounted to 2.99 euro (2.79 euro).PRODUCT DEVELOPMENTThe company invested 1.2 million euro (1.1 million euro) in long-termproduct development projects during the financial period. Productdevelopment accounted for 4.3 percent (3.1 %) of the net sales.Okmetic engaged in several strategic research projects. R&D workfocused on sensor wafers which are important to Okmetic.PERSONNELOn average, Okmetic employed 340 people (361). At the end of theperiod, 309 of the group's employees worked in Finland, 31 in the USand three in Japan. Majority of the company's personnel in Finlandwere temporarily laid off from one to six weeks in February-June2009. Foreign group units have also adjusted staff numbers to theprevailing market situationBUSINESS RISKSOkmetic's silicon wafer sales are targeted at the sensor andsemiconductor industries. The demand for semiconductor wafers issensitive to economic fluctuations and changes in the marketsituation can be sudden and dramatic. The demand for sensor wafers issignificantly more stable and sales of sensor wafers are developingfavourably. The success of the sales strategy hinges on trouble-freecontract manufacturing.Okmetic's share of the global silicon wafer market is around onepercent and the market prices have an effect on the price developmentof the company's products. The majority of sales are conducted in USdollars. The Japanese yen is another notable trading currency.Despite hedging, the company remains exposed to exchange ratefluctuations.Great volumes of electricity are used in Okmetic's production. Themassive and long-term electricity hedging measures will have animpact on the result for the period if the price of electricitychanges significantly.SHARE PRICE DEVELOPMENT AND TRADINGA total of 2.3 million shares (3.9 million shares) were tradedbetween 1 January and 30 June 2009, representing 13.5 percent (23.1%) of the share total of 16.9 million. The lowest quotation of theperiod was 1.81 euro (2.20 euro) and the highest was 2.99 euro pershare (3.14 euro), with an average of 2.31 euro (2.63 euro). Theclosing quotation for the period was 2.70 euro (2.55 euro). The totalmarket value of the share capital amounted to 45.6 million euro atthe end of the financial period (43.1 million euro).OWN SHARESThe company has not redeemed its own shares.AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON REPURCHASING THECOMPANY'S OWN SHARESThe extraordinary general meeting held on 6 November 2008 authorisedthe board of directors to decide on repurchasing the company's ownshares as follows. The aggregate number of shares repurchased on thebasis of the authorisation cannot exceed 1,688,750 shares, whichrepresents 10 percent of all the shares of the company.Only unrestricted shareholders' equity can be used to repurchase thecompany's own shares under the authorisation. Own shares can berepurchased at a price determined by public trading on the day ofrepurchase or at another market-based price. The authorisation willremain in force until the annual general meeting of spring 2010,although in any case not past 6 May 2010.AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON TRANSFERRINGRIGHTS TO THE COMPANY'S OWN SHARESThe extraordinary general meeting held on 6 November 2008 authorisedthe board of directors to decide on transferring rights to thecompany's own shares as follows. The aggregate number of rightstransferred on the basis of the authorisation cannot exceed 1,688,750shares, which represents 10 percent of all the shares of the company.The authorisation will remain in force until further notice, althoughin any case not past 30 June 2013.AUTHORITY OF THE BOARD OF DIRECTORS TO INCREASE SHARE CAPITALThe annual general meeting held on 2 April 2009 authorised the boardof directors to decide on increasing the company's share capital. Theaggregate number of shares issued on the basis of the authorisationcannot exceed 3,377,500 shares, which represents approximately 20percent of all the shares of the company.The board of directors was authorised to decide on all the terms andconditions concerning the issue of shares and other shareentitlements. The authorisation relates to the issuance of newshares. Issuance of shares and other share entitlements can becarried out as a directed issue. The authorisation is effective untilthe following annual general meeting.The board has not taken advantage of the authorisations by 31 July2009.CONVERTIBLE BONDS AND OPTION PROGRAMMESOkmetic has no convertible bonds or option programmes at the moment.CONDENSED FINANCIAL STATEMENTS AND TABLES 1 JANUARY - 30 JUNE 2009(unaudited)These interim financial statements have been prepared in accordancewith IAS 34 standard.In preparing these interim financial statements, Okmetic has followedthe same accounting policies as in the financial statements for 2008except that the company has adopted the following new or revisedstandards as of 1 January 2009:- IAS 1, Presentation of Financial Statements - amendment- IFRS 8, Operating SegmentsThe amendment to IAS 1 affects the way the income statement andchanges in shareholders' equity are presented. The amendment to IFRS8 does not affect the information presented for individual segments,because the segment data provided by the group have always been basedon the group's internal reporting structure.CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME1,000 euro 1.4.- 1.4.- 1.1.- 1.1.- 1.1.- 30.6.09 30.6.08 30.6.09 30.6.08 31.12.08Net sales 13,538 16,992 28,379 34,025 67,867Cost of sales -11,955 -12,943 -24,375 -25,514 -50,687Gross profit 1,583 4,049 4,004 8,511 17,180Other income and expenses -895 -1,312 -2,789 -3,232 -8,704Operating profit 688 2,737 1,215 5,279 8,476Financial income andexpenses -642 -155 -352 -1,063 -2,900Profit before tax 46 2,582 863 4,216 5,576Income tax 19 -150 203 -144 248Profit for the period 64 2,432 1,066 4,072 5,825Other comprehensiveincome:Translation differences -349 94 -103 -264 560Available-for-salefinancial assets - -298 - -619 114Other comprehensive incomefor the period, net of tax -349 -203 -103 -883 674Total comprehensive incomefor the period -285 2,228 963 3,189 6,499Profit for the periodattributable to:Equity holders of theparent company 64 2,432 1,066 4,072 5,825Total comprehensive incomeattributable to:Equity holders of theparent company -285 2,228 963 3,189 6,499Basic and diluted earningsper share, euro 0.00 0.14 0.06 0.24 0.34CONDENSED CONSOLIDATED BALANCE SHEET1,000 euro Jun 30, Jun 30, Dec 31, 2009 2008 2008AssetsNon-current assetsProperty, plant and equipment 36,714 40,639 38,848Available-for-sale financial assets - 1,821 -Other receivables 4,419 5,100 4,619Total non-current assets 41,133 47,560 43,468Current assetsInventories 7,171 8,218 10,753Receivables 9,192 10,827 9,289Cash and cash equivalents 17,264 13,127 17,975Total current assets 33,626 32,172 38,016Total assets 74,759 79,732 81,484Equity and liabilitiesEquityEquity attributable to equity holdersof the parent companyShare capital 11,821 11,821 11,821Other equity 38,616 35,258 38,568Total equity 50,437 47,080 50,389LiabilitiesNon-current liabilities 12,541 15,719 14,027Current liabilities 11,781 16,934 17,068Total liabilities 24,322 32,653 31,095Total equity and liabilities 74,759 79,732 81,484CONDENSED CONSOLIDATED CASH FLOW STATEMENT1,000 euro Jan 1- Jan 1- Jan 1- Jun 30, Jun 30, Dec 31, 2009 2008 2008Cash flows from operating activities:Profit before tax 863 4,216 5,576Adjustments 3,406 4,039 11,272Change in working capital 166 -1,748 -2,935Interest received 221 209 424Interest paid and other financial items -391 -923 -1,135Tax paid - -16 -26Net cash from operating activities 4,265 5,776 13,177Cash flows from investing activities:Proceeds from investing activities 641 - 469Capital expenditure -1,579 -1,172 -2,646Net cash used in investing activities -938 -1,172 -2,177Cash flows from financing activities:Repayments of long-term borrowings -3,023 -2,873 -4,748Payments of finance lease liabilities -74 -112 -198Dividends paid -844 -1,689 -1,689Net cash used in financing activities -3,942 -4,674 -6,634Increase (+) / decrease (-) in cashand cash equivalents -615 -70 4,365Exchange rate changes -96 -111 301Cash and cash equivalents at thebeginning of the period 17,975 13,308 13,308Cash and cash equivalents at the endof the period 17,264 13,127 17,975CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY Equity attributable to equity holders of parent company1,000 euro Share Share Trans- Fair Retained Total capital premium lation value earnings equity diffe- reserve rencesBalance at 31Dec 2008 11,821 20,115 635 - 17,818 50,389Totalcomprehensiveincome for theperiod -103 1,066 963Dividenddistribution -844 -844Equitycomponent ofconvertibleloan notes -70 -70Balance at 30Jun 2009 11,821 20,045 531 - 18,039 50,437Balance at 31Dec 2007 11,821 20,186 75 -114 13,682 45,649Totalcomprehensiveincome for theperiod -264 -619 4,072 3,189Dividenddistribution -1,689 -1,689Equitycomponent ofconvertibleloan notes -70 -70Balance at30 June 2008 11,821 20,115 -189 -733 16,065 47,080CHANGES IN PROPERTY, PLANT AND EQUIPMENT1,000 euro Jan 1 - Jan 1 - Jan 1 - Jun 30, Jun 30, Dec 31, 2009 2008 2008Carrying amount at thebeginning of the period 38,848 43,355 43,355Additions 1,388 1,195 2,773Disposals - - -537Depreciation -3,453 -3,516 -7,041Exchange differences -69 -395 298Carrying amount at the endof the period 36,714 40,639 38,848CHANGES IN FINANCIAL LIABILITIES1,000 euro Jan 1 - Jan 1 - Jan 1- Jun 30, Jun 30, Dec 31, 2009 2008 2008Carrying amount at the beginning ofthe period 17,389 22,259 22,259Proceeds of loans from financialinstitutions - - 999Repayments of loans from financialinstitutions -2,021 -1,872 -4,744Repayments of subordinated loans -928 -928 -928Changes in finance lease liabilities -74 -112 -198Carrying amount at the end of theperiod 14,365 19,347 17,389DIVIDENDS PAIDIn April, the company distributed a dividend of 0.8 million euro ofthe profit accrued in 2008, representing a 0.05 euro dividend pershare.COMMITMENTS AND CONTINGENCIES1,000 euro Jun 30, Jun 30, Dec 31, 2009 2008 2008Loans secured with collaterals 12,167 14,500 13,333Collaterals 24,964 29,001 24,964Off-balance sheet lease commitments 97 223 165Capital commitments 112 - 574Nominal values of derivative contractsCurrency forward agreements 396 - -Currency options, call - 2,348 -Electricity derivatives 2,587 1,827 2,961Interest rate swaps 7,071 - -Fair values of derivative contractsCurrency forward agreements 43 - -Currency options, call - 131 -Electricity derivatives -460 946 -540Interest rate swaps -14 - -The contract price of the derivatives has been used as the nominalvalue of the underlying asset. Derivative contracts are for hedging.RELATED PARTY TRANSACTIONSKey management compensation during the period under review amountedto 644,000 euro (788,000 euro).KEY FIGURES SHOWING FINANCIAL PERFORMANCE1,000 euro Jan 1- Jan 1- Jan 1- Jun 30, Jun 30, Dec 31, 2009 2008 2008Net sales 28,379 34,025 67,867Change in net sales compared to theprevious year's period, % -16.6 3.3 5.0Export and foreign operations share of netsales, % 95.9 95.2 95.6Operating profit before depreciation(EBITDA) 4,668 8,795 15,517 % of net sales 16.4 25.8 22.9Operating profit 1,215 5,279 8,476 % of net sales 4.3 15.5 12.5Profit before tax 863 4,216 5,576 % of net sales 3.0 12.4 8.2Return on equity, % 4.2 17.6 12.1Return on investment, % 3.7 15.4 9.9Non-interest-bearing liabilities 9,957 13,305 13,707Net interest-bearing liabilities -2,898 6,220 -586Net gearing ratio, % -5.7 13.2 -1.2Equity ratio, % 67.7 60.1 62.8Capital expenditure 1,388 1,195 2,773 % of net sales 4.9 3.5 4.1Depreciation 3,453 3,516 7,041Research and developmentexpenditure 1) 1,213 1,048 2,261 % of net sales 4.3 3.1 3.3Average number of personnel during the period 340 361 364Personnel at the end of the period 343 370 3631) Research and development expenditure has been presented in grossfigures and only long-term projects based on research program havebeen taken into account.KEY FIGURES PER SHAREEuro Jun 30, Jun 30, Dec 31, 2009 2008 2008Earnings per share basic and diluted 0.06 0.24 0.34Equity per share 2.99 2.79 2.98Dividend per share - - 0.05Dividends/earnings, % - - 14.5Effective dividend yield, % - - 2.1Price/earnings(P/E) 42.8 10.6 7.0Share price performance(Jan 1-)Average trading price 2.31 2.63 2.63Lowest trading price 1.81 2.20 2.15Highest trading price 2.99 3.14 3.14Trading price at the end of theperiod 2.70 2.55 2.40Market capitalisation at the end ofthe period, 1,000 euro 45,596 43,063 40,530Trading volume (Jan 1-)Trading volume, transactions 2,288,112 3,898,409 8,355,374In relation to weighted averagenumber of shares, % 13.5 23.1 49.5Trading volume, euro 5,293,226 10,249,556 22,002,739The weighted average number ofshares during the period underreview adjusted by the share issue 16,887,500 16,887,500 16,887,500The number of shares at the end ofthe period adjusted by the shareissue 16,887,500 16,887,500 16,887,500QUARTERLY KEY FIGURES1,000 euro 10-12/09 7-9/09 4-6/09 1-3/09Net sales 13,538 14,841 Compared to previous quarter % -8.8 -5.8Operating profit 688 527 % of net sales 5.1 3.6Profit before tax 46 818 % of net sales 0.3 5.5Net cash flow generated from:Operating activities 4,761 -496Investing activities -786 -152Financing activities -3,905 -37Increase/decrease in cash and cashequivalents 70 -685Personnel at the end of the period 343 338 10-12/08 7-9/08 4-6/08 1-3/08Net sales 15,751 18,090 16,992 17,034 Compared to previous quarter % -12.9 6.5 -0.2 7.9Operating profit 1,108 2,089 2,737 2,542 % of net sales 7.0 11.5 16.1 14.9Profit before tax -1,323 2,683 2,582 1,634 % of net sales -8.4 14.8 15.2 9.6Net cash flow generated from:Operating activities 2,878 4,522 3,495 2,281Investing activities -716 -289 -841 -331Financing activities -1,912 -48 -4,616 -58Increase/decrease in cash and cashequivalents 250 4,185 -1,962 1,892Personnel at the end of the period 363 361 370 359DEFINITIONS OF KEY FINANCIAL FIGURESOperating profit before = Operating profit + depreciationdepreciation (EBITDA)Return on equity, % (ROE) = Profit/loss for the period from continuing operations x 100 Equity (average for the period)Return on investment, % = (Profit/loss before tax + interest and(ROI) other financial expenses) x 100 Balance sheet total - non-interest bearing liabilities (average for the period)Equity ratio, % = Equity x 100 Balance sheet total - advances receivedNet gearing ratio, % = (Interest-bearing liabilities - cash and cash equivalents) x 100 EquityEarnings per share = Profit/loss for the period attributable to the equity holders of the parent company Adjusted weighted average number of shares in issue during the periodEquity per share = Equity attributable to the equity holders of the parent company Adjusted number of shares at the end of the periodDividend per share = Dividend for the period Adjusted number of shares at the end of the periodEffective dividend yield, % = Dividend per share x 100 Trading price at the end of the periodPrice/earnings ratio (P/E) = Last adjusted trading price at the end of the period Earnings per shareAverage trading price = Total traded amount in euro Adjusted number of shares traded during the periodMarket capitalisation at the = Number of shares at the end of theend of the period period x trading price at the end of the periodTrading volume = Number of shares traded during the period Weighted average number of shares during the periodAll figures of the financial tables are rounded, and consequently thesum of individual figures can deviate from the presented sum figure.The figures are unaudited. In the written report, the figures inparenthesis refer to the corresponding period in the previous year.The future estimates and forecasts in this interim report bulletinare based on company management's current knowledge. Actual eventsand results may differ from the estimates presented here.OKMETIC OYJBoard of directorsPRESS CONFERENCEThe company will not arrange a press conference for the release ofthis interim report.For further information, please contact:President Antti Rasilo, Okmetic Oyjtel. +358 40 746 1351, email: antti.rasilo(at)okmetic.comSenior Vice President, Finance Esko Sipilä, Okmetic Oyj,tel. +358 9 5028 0286, email: esko.sipila(at)okmetic.comDistribution:NASDAQ OMX HelsinkiPrincipal mediawww.okmetic.comOKMETIC IN BRIEFTake it higherOkmetic is a technology company which supplies tailor-made siliconwafers for sensor and semiconductor industries and sells itstechnological expertise to the solar energy industry. Okmeticprovides its customers with solutions that boost theircompetitiveness and profitability.Okmetic's silicon wafers are part of a further processing chain thatproduces end products that improve human interaction and quality oflife. Okmetic's products are based on high-tech expertise thatgenerates added value for customers, innovative product developmentand an extremely efficient production process.Okmetic has a global customer base and sales network, productionplants in Finland and the US and contract manufacturers in Japan andChina.Okmetic's shares are listed on NASDAQ OMX Helsinki under the codeOKM1V. For more information on the company, please visit our websiteat www.okmetic.com.http://hugin.info/132025/R/1331793/315243.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Tagesgeld-Konditionen
Pressemitteilungen der Druckerei WIRmachenDRUCK finden Sie auf wir-machen-druck.de unter Aktuelles.
Hochwertiges und günstiges Spielzeug, sowie Bastelbedarf und Bastelmaterial gibt es im didagoshop.
Moderne Badmöbel und viele tolle Möbel für Ihr Zuhause.
Für ein effektives und erfolgreiches Direktmarketing. Adressen kaufen bei Best Adress.
Mit einem einfachen Strompreisvergleich können Sie jeden Monat sparen.
Günstige Kredite für Selbstständige und Freiberufler - auch in schwierigen Fällen!
Kfz Ersatzteile von 100Pro-Ersatzteile.de, Autoteile in Erstausrüsterqualität.
Diese Pressemeldung bookmarken bei...